RecruitingNot Applicable

Evaluation of the Effectiveness, Safety, and Cost of a Smart Hospital System for Patients With Chronic Obstructive Pulmonary Disease

South Korea198 participantsStarted 2024-09-05

Plain-language summary

This study aims to analyze the effectiveness/safety/cost of the Smart Homespital system that provides a service that allows patients with Chronic Obstructive Pulmonary Disease to easily access and use biosignals generated using biosignal collection medical equipment at home.

Who can participate

Age range40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Pre FEV1 \< 80% \*\*or\*\*
✓. Pre FVC \< 80% \*\*or\*\*
✓. DLCO \< 60%

Exclusion criteria

✕. Patients who do not agree to participate in the study.
✕. Patients who fail to use the medical device equipment.
✕. Patients where tracking during the study period is expected to be impossible.
✕. Patients who have difficulty communicating verbally.
✕. Patients who are bedridden or unable to exercise at all due to severe cardiorespiratory dysfunction.
✕. Patients receiving hospital-centered rehabilitation treatment during the study period.

What they're measuring

Respiratory symptom questionnaire

Timeframe: After applying the Smart Homespital system(12weaks)

Trial details

NCT IDNCT06601777

SponsorYonsei University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-05-02

View on ClinicalTrials.gov More Chronic Obstructive Pulmonary Disease trials